Zhongke Health Industry Group Co., Ltd. was established in 1984 and entered the health food field since 1996. In 2001, it was reorganized into a mixed-ownership enterprise, responsible for the promotion of Zhongke products worldwide. Zhongke Group is a member of the China Healthcare Enterprise Summit, and as the president unit, he undertakes the convening work and presides over the summit activities.

Zhongke Pharmaceutical is committed to independent research and development, and has obtained 52 health food certificates approved by the Ministry of Health and the Drug Administration, and 2 pending approval. In terms of drug research and development, it currently has 2 new drug certificates and 2 new drug clinical approval documents with independent intellectual property rights. Phase II and Phase III clinical research is underway. There are currently 59 patents, including 24 invention patents, and one is PCT International invention patent. A total of three monographs have been published, and another one is being edited. 20 papers have been published in core journals, including 2 in foreign journals.

Nanjing Zhongke Pharmaceutical Co., Ltd. is a wholly-owned subsidiary of Zhongke Health Industry Group Co., Ltd., responsible for the production and research and development of Zhongke products. Zhongke Health Industry Group Co., Ltd. does not involve health product production and sales, etc., and is from Nanjing Zhongke Pharmaceutical Co., Ltd. is responsible. Zhongke Pharmaceutical was established in 2005, covering an area of ​​40 mu, with a construction area of ​​10,000M2. It has 3 production workshops that have passed the GMP review, solid preparations and soft capsule production lines such as capsules and powders, and has passed the ISO9001, ISO14001, and OHSMS18001 integrated system certification. .